← Home
Modern Wisdom · August 24, 2026 · 2h 5m

“Age Reversal Is Coming.” Inside The First Human Trials - Dr David Sinclair

Dr. David Sinclair discusses the frontier of age-reversal science, including a first-of-its-kind human trial to reverse blindness using cellular reprogramming. The conversation covers the biology of aging as a treatable disease, why Sinclair believes scientists are closer than ever to radical life extension, and the lifestyle interventions he personally prioritizes—from fasting and specific exercise protocols to reframing the debate around protein intake and longevity. The episode also examines controversial longevity drugs like metformin and NAD boosters, explores the potential of GLP-1 agonists to protect against dementia, and unpacks the psychological impact of believing you can influence your own aging trajectory.

This summary was generated from show notes and public descriptions, not from a full transcript review. Details may contain inaccuracies.

Preview

Human Age Reversal Trials Begin00:00:58
Sinclair discusses a first-in-human clinical trial, ER100, which aims to reverse blindness caused by optic nerve damage using partial cellular reprogramming.
Sinclair argues that aging should be classified and treated as a disease rather than an inevitability, because all of its aspects—frailty, organ failure, cognitive decline—are driven by biological processes that can be slowed or reversed.

5 more ideas, 1 references & all timestamps

This episode is in its early-access window. The full breakdown unlocks free in about 45 hours — Pro members read everything the moment it lands.

Read it now with Pro$10/mo · founding $96/yr
Was this useful?